FMP

FMP

Blog
Screener
Extras

IMGN - ImmunoGen, Inc.

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates incl

photo-url-https://financialmodelingprep.com/image-stock/IMGN.png

ImmunoGen, Inc.

IMGN

NASDAQ

31.23 USD

0.005 (0.02%)

About

ceo

Mr. Mark Joseph Enyedy

sector

Healthcare

industry

Biotechnology

website

https://www.immunogen.com

exchange

NASDAQ

Description

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeut...

CIK

0000855654

ISIN

US45253H1014

CUSIP

45253H101

Address

830 Winter Street

Phone

781 895 0600

Country

US

Employee

277

IPO Date

Nov 17, 1989

Summary

CIK

0000855654

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

45253H101

ISIN

US45253H1014

Country

US

Price

31.23

Beta

1.17

Volume Avg.

8.29M

Market Cap

8.73B

Shares

-

52-Week

3.61-31.25

DCF

-11.66

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-111.55

P/B

-

Website

https://www.immunogen.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest IMGN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep